23andMe Holding Co. (ME) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
870 MARKET STREET SAN FRANCISCO, CA 94102 |
| State of Incorp. | |
| Fiscal Year End | March 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2025 MRQ | 3/31/2025 | 12/31/2024 MRQ | 3/31/2024 | 3/31/2023 | 3/31/2022 | 12/31/2020 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 38,248 | 79,350 | 216,488 | 386,849 | 553,182 | 788 | |||
| Cash and cash equivalent | 38,248 | 79,350 | 216,488 | 386,849 | 553,182 | 788 | |||
| Restricted cash and investments | 7,746 | 1,664 | 1,399 | 1,399 | 1,599 | ||||
| Receivables | 2,731 | 12,305 | 9,075 | 1,897 | 3,380 | ||||
| Inventory, net of allowances, customer advances and progress billings | 15,558 | 21,407 | 12,465 | 10,247 | 10,789 | ||||
| Inventory | 15,558 | 21,407 | 12,465 | 10,247 | 10,789 | ||||
| Prepaid expense | 8,827 | 11,674 | 9,296 | 449 | |||||
| Deferred costs | 5,173 | 9,920 | 4,792 | 5,376 | 7,700 | ||||
| Disposal group, including discontinued operation | 1,057 | ||||||||
| Other current assets | 2,826 | 2,606 | 1,794 | ||||||
| Other undisclosed current assets | 21,598 | 21,594 | 19,224 | 25,139 | |||||
| Total current assets: | 102,707 | 161,577 | 255,309 | 424,992 | 601,789 | 1,237 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 533 | 35,013 | 48,894 | 56,078 | 55,577 | ||||
| Property, plant and equipment | 1,258 | 19,226 | 28,351 | 38,608 | 49,851 | ||||
| Intangible assets, net (including goodwill) | 25,335 | 27,315 | 33,255 | 397,264 | 425,649 | ||||
| Goodwill | 351,744 | 351,744 | |||||||
| Intangible assets, net (excluding goodwill) | 25,335 | 27,315 | 33,255 | 45,520 | 73,905 | ||||
| Asset, held-in-trust | 508,645 | ||||||||
| Restricted cash and investments | 5,300 | 12,274 | 6,974 | 6,974 | 6,974 | ||||
| Disposal group, including discontinued operation, noncurrent assets | 481 | ||||||||
| Other noncurrent assets | 5,365 | 812 | 1,868 | 3,021 | 2,593 | ||||
| Other undisclosed noncurrent assets | 19,396 | 20,724 | 20,516 | 15,661 | 9,635 | ||||
| Total noncurrent assets: | 57,187 | 115,845 | 139,858 | 517,606 | 550,279 | 508,645 | |||
| TOTAL ASSETS: | 159,894 | 277,422 | 395,167 | 942,598 | 1,152,068 | 509,882 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 16,048 | 74,707 | 53,834 | 79,354 | 82,518 | 32 | |||
| Accounts payable | 549 | 7,781 | 11,571 | 12,924 | 37,930 | ||||
| Accrued liabilities | 15,499 | 66,926 | 42,263 | 66,430 | 44,588 | 32 | |||
| Deferred revenue | 49,347 | 62,919 | 64,827 | 62,521 | 62,939 | ||||
| Debt | 1,500 | ||||||||
| Deferred compensation liability | 17,799 | ||||||||
| Restructuring reserve | 22 | ||||||||
| Disposal group, including discontinued operation | 9,823 | ||||||||
| Other undisclosed current liabilities | 7,308 | 5,891 | 8,648 | 7,541 | 7,784 | ||||
| Total current liabilities: | 72,703 | 153,340 | 127,331 | 149,416 | 153,241 | 19,331 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 78,524 | ||||||||
| Liabilities, other than long-term debt | 429 | 61,362 | 79,316 | 79,243 | 4,647 | ||||
| Deferred revenue | 10,000 | ||||||||
| Disposal group, including discontinued operation, liabilities | 4,925 | ||||||||
| Other liabilities | 224 | 1,784 | 1,471 | 1,480 | 4,647 | ||||
| Operating lease, liability | 205 | 54,653 | 67,845 | 77,763 | 78,524 | ||||
| Other undisclosed noncurrent liabilities | 113,504 | ||||||||
| Total noncurrent liabilities: | 113,933 | 61,362 | 79,316 | 79,243 | 83,171 | ||||
| Other undisclosed liabilities | 68,785 | ||||||||
| Total liabilities: | 186,636 | 214,702 | 206,647 | 228,659 | 236,412 | 88,116 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (26,742) | 62,720 | 188,520 | 713,939 | 915,656 | 5,000 | |||
| Common stock | 3 | 3 | 49 | 46 | 45 | 1 | |||
| Additional paid in capital | 2,427,228 | 2,417,343 | 2,361,559 | 2,220,897 | 2,110,160 | 53,601 | |||
| Accumulated other comprehensive income (loss) | (620) | 179 | |||||||
| Accumulated deficit | (2,453,973) | (2,354,626) | (2,173,088) | (1,506,384) | (1,194,728) | (48,603) | |||
| Other undisclosed equity, attributable to parent | 1 | ||||||||
| Other undisclosed equity | 416,766 | ||||||||
| Total equity: | (26,742) | 62,720 | 188,520 | 713,939 | 915,656 | 421,766 | |||
| TOTAL LIABILITIES AND EQUITY: | 159,894 | 277,422 | 395,167 | 942,598 | 1,152,068 | 509,882 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2025 TTM | 3/31/2025 | 12/31/2024 TTM | 3/31/2024 | 3/31/2023 | 3/31/2022 | 12/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 189,896 | 144,747 | 219,638 | 299,489 | 271,893 | |||
| Revenue from related parties | ✕ | ✕ | ✕ | ✕ | 47,448 | 46,064 | ||
| Cost of revenue | (89,892) | (62,000) | (120,261) | (164,993) | (138,948) | |||
| Gross profit: | 100,004 | 82,747 | 99,377 | 134,496 | 132,945 | |||
| Operating expenses | (340,644) | (251,743) | (780,845) | (458,507) | (387,098) | |||
| Operating income (loss): | (240,640) | (168,996) | (681,468) | (324,011) | (254,153) | |||
| Nonoperating income (expense) | 1,021 | 312 | 506 | (93) | (83) | |||
| Investment income, nonoperating | (2,375) | |||||||
| Gain on contract termination | 15 | |||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (239,619) | (168,684) | (680,962) | (324,104) | (254,236) | |||
| Other undisclosed income (loss) from continuing operations before income taxes | 5,865 | 14,331 | 9,676 | 33,266 | ||||
| Income (loss) from continuing operations before income taxes: | (239,619) | (162,819) | (666,631) | (314,428) | (220,970) | |||
| Income tax expense (benefit) | 41 | 41 | (73) | 2,772 | 3,480 | |||
| Income (loss) from continuing operations: | (239,578) | (162,778) | (666,704) | (311,656) | (217,490) | |||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | ✕ | (217,490) | ✕ | |
| Net income (loss): | (239,578) | (162,778) | (666,704) | (311,656) | (217,490) | |||
| Other undisclosed net loss attributable to parent | (41,307) | (18,760) | ||||||
| Net income (loss) available to common stockholders, diluted: | (280,885) | (181,538) | (666,704) | (311,656) | (217,490) | |||
Comprehensive Income ($ in thousands)
| 6/30/2025 TTM | 3/31/2025 | 12/31/2024 TTM | 3/31/2024 | 3/31/2023 | 3/31/2022 | 12/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (239,578) | (162,778) | (666,704) | (311,656) | (217,490) | |||
| Other comprehensive income (loss) | 620 | (799) | 179 | |||||
| Other undisclosed comprehensive loss | ||||||||
| Comprehensive income (loss): | (239,578) | (162,778) | (666,084) | (312,455) | (217,311) | |||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (41,307) | (18,760) | ||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (280,885) | (181,538) | (666,084) | (312,455) | (217,311) | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.